We're thrilled to lead Telepatia's $33M Series A.
@Nicobot01's father was a physician in Colombia who died at 58 from a drug interaction AI could have flagged in seconds. Nicolás is building the product that could have saved him.
Telepatia is the AI-native clinical platform for Latin America spanning an AI scribe, clinical decision support, and AI auditor, each connected to every data source across the hospital.
Since launching in July 2025, the platform has deployed across 25+ hospital systems in Brazil, Colombia, and Mexico, reaching 14M patients.
Welcome, Nicolás and the Telepatia team.
By @daisydwolf, @GEVS94, and @evajsteinman
Nicolás Abad (@Nicobot01)
Telepatia has raised $42 million, including a $33 million Series A led by a16z.
My father’s nickname was Telepatia.
He was a doctor who passed away at 58 from a preventable cause. A few days after his death, ChatGPT launched. My first thought was that an AI Doctor would have saved his life as a patient, and that he would have loved using one as a doctor. So we built it: an AI Doctor for doctors, by doctors.
Telepatia's AI Doctor is live in more than 25 public and private health institutions, home to more than 100,000 doctors and nurses throughout Latin America 🇧🇷🇨🇴🇲🇽🇨🇱🇦🇷
We're building an AI Doctor and our goal is to bring Latin America its first Nobel Prize in Medicine since 1984.
Video
— https://nitter.net/Nicobot01/status/2067304722554605752#m